Citrotech Inc. is a US-listed company in the specialty chemicals industry. Its financial year ends in December.
Loading chart…
Third-party market data · may be delayed
Under review: every model's value for Citrotech Inc. is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.
Under review: free cash flow after stock pay is not positive. We'll show the comparison once resolved.
Citrotech Inc. valuation: adjust assumptions and compare models →
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Citrotech has little or no product revenue yet; it used $8m of cash in the twelve months to June 2026. It passes 5 of our 6 financial-health checks.
Our model value for Citrotech is under review, so past values are not shown until it is resolved.
Source: 10-Q/A filed August 10, 2026 on SEC EDGAR · Financials · Valuation
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Citrotech Inc.'s trailing-twelve-month revenue fell 26.4% year on year, with a free-cash-flow margin of -579.5%. Where it stands out: long-term debt as % of assets of 0.0% ranks 1 of 36 specialty chemicals companies we cover. Where it lags: free-cash-flow margin of -579.5% ranks 42 of 42 specialty chemicals companies we cover.
Current signal Revenue growth decelerating: TTM revenue growth slowed to -26.4% (-57.0pp vs the prior quarter), the 2nd consecutive quarterly slowdown.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.
We value Citrotech Inc. as an operating company, with every model that fits that kind of business. Cost of equity 9.1%: the 10-year Treasury yield (4.9%) plus a beta of 0.92 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. | — | Does not apply: This model is withheld pending its input or assumption review. |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | — | Does not apply: This model is withheld pending its input or assumption review. |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | — | Does not apply: This model is withheld pending its input or assumption review. |
| Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. | — | Does not apply: This model is withheld pending its input or assumption review. |
| Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. | ~$0.0 ~$0.1–$0.1 | Left out: out of range vs price (0.01x) |
| Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. | — | Combined value withheld. Review the individual models and their assumptions. |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Citrotech Inc. with Specialty Chemicals in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
| At fiscal year end | 2025 |
|---|---|
| Share price | $8.08 |
| Market value | $101m |
| + Net debt (− = net cash) | −$6m |
| Enterprise value | $94m |
| Multiples | |
| Price / sales | 42.2x |
| Price / earnings | — |
| Price / free cash flow | — |
| EV / EBITDA | — |
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | −$0.88 | +70% | $2m | — |
| Next | −$0.56 | — | $22m | +1095% |
In the last 30 days, 1 analyst raised Citrotech Inc.'s forecast and 0 cut it.
Average of analysts' published estimates (third-party data).
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 60 days ago | −$0.97 | −$0.68 |
| 30 days ago | −$0.97 | −$0.68 |
| 7 days ago | −$0.97 | −$0.68 |
| Now | −$0.88 | −$0.56 |
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | −$0.21 | −$0.18 | +14.3% |
Adjusted EPS as companies report it, against the average analyst estimate.
| Calendar year | 2026 to date |
|---|---|
| Return | |
| CITR | −69% |
| Industry peers (median) | +6% |
| S&P 500 | +11% |
| Months that ended higher | |
| CITR | 36% |
| S&P 500 | 46% |
| Largest fall from a high during the year | |
| CITR | −76% |
| S&P 500 | −9% |
Worst fall since December 4, 2025: 76% from March 24, 2026 to November 2, 2026. Getting back needed a 309% gain, and the shares have not yet recovered.
Source: SEC EDGAR filings. Retrieved October 29, 2026.
| Period | Revenue (TTM) |
|---|---|
| FY23 Q3 | $260.9K |
| FY23 Q4 | $520.6K |
| FY24 Q1 | $898.1K |
| FY24 Q2 | $1.1M |
| FY24 Q3 | $1M |
| FY24 Q4 | $808.4K |
| FY25 Q1 | $1.3M |
| FY25 Q2 | $1.8M |
| FY25 Q3 | $2M |
| FY25 Q4 | $2.4M |
| FY26 Q1 | $1.8M |
| FY26 Q2 | $1.3M |
Source: SEC EDGAR filings. Retrieved October 29, 2026.
| Period | Revenue growth, TTM YoY |
|---|---|
| FY23 Q3 | 331.2% |
| FY23 Q4 | 730.0% |
| FY24 Q1 | 659.0% |
| FY24 Q2 | 915.4% |
| FY24 Q3 | 283.6% |
| FY24 Q4 | 55.3% |
| FY25 Q1 | 49.7% |
| FY25 Q2 | 71.6% |
| FY25 Q3 | 101.3% |
| FY25 Q4 | 194.6% |
| FY26 Q1 | 30.7% |
| FY26 Q2 | -26.4% |
Source: SEC EDGAR filings. Retrieved October 29, 2026.
| Period | Operating margin (TTM) |
|---|---|
| FY23 Q3 | -3900.2% |
| FY23 Q4 | -1939.5% |
| FY24 Q1 | -1371.7% |
| FY24 Q2 | -1198.9% |
| FY24 Q3 | -428.5% |
| FY24 Q4 | -656.2% |
| FY25 Q1 | -455.6% |
| FY25 Q2 | -449.2% |
| FY25 Q3 | -591.3% |
| FY25 Q4 | -692.7% |
| FY26 Q1 | -995.2% |
| FY26 Q2 | -1330.5% |
Source: SEC EDGAR filings. Retrieved October 29, 2026.
| Period | FCF margin (TTM) |
|---|---|
| FY24 Q2 | -146.1% |
| FY24 Q3 | -171.2% |
| FY24 Q4 | -239.7% |
| FY25 Q1 | -173.6% |
| FY25 Q2 | -177.9% |
| FY25 Q3 | -209.7% |
| FY25 Q4 | -254.6% |
| FY26 Q1 | -420.7% |
| FY26 Q2 | -579.5% |
| Fiscal year | 2021 Dec 2021 | 2022 Dec 2022 | 2023 Dec 2023 | 2024 Dec 2024 | 2025 Dec 2025 | LTM Jun 2026 |
|---|---|---|---|---|---|---|
| Income | ||||||
| Revenue | 0 | 0 | 1 | 1 | 2 | 1 |
| Gross profit | 0 | 0 | 0 | 0 | 1 | −0 |
| EBITDA | −0 | −3 | −10 | −5 | −16 | −18 |
| Operating income | −0 | −3 | −10 | −5 | −16 | −18 |
| Net income | −0 | −3 | −10 | −7 | −37 | −24 |
| Diluted EPS | $0.00 | $0.00 | −$1.20 | −$0.82 | −$2.96 | — |
| Growth (year on year) | ||||||
| Revenue | — | — | +730.0% | +55.3% | +194.6% | −26.4% |
| Margins | ||||||
| Gross margin | — | 97.0% | 74.4% | 18.9% | 22.3% | −5.2% |
| EBITDA margin | — | <−999% | <−999% | −623.5% | −678.9% | <−999% |
| Operating margin | — | <−999% | <−999% | −656.2% | −692.7% | <−999% |
| Net margin | — | <−999% | <−999% | −851.3% | <−999% | <−999% |
| Free-cash-flow margin | — | <−999% | −233.5% | −239.7% | −254.6% | −579.5% |
| Cash flow | ||||||
| Cash from operations | −0 | −1 | −1 | −2 | −6 | −8 |
| Capital spending | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −0 | −1 | −1 | −2 | −6 | −8 |
| Stock-based pay | 0 | 2 | 9 | 3 | 19 | 10 |
| Free cash flow after stock pay | −0 | −3 | −10 | −5 | −25 | −18 |
| Balance sheet | ||||||
| Cash | 0 | 0 | 1 | 1 | 6 | 3 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Net debt (negative = net cash) | 0 | −0 | −0 | −1 | −6 | −3 |
| Diluted shares | 2m | 6m | 8m | 8m | 12m | — |
| Quarter | 2024 Q3 Sept 2024 | 2024 Q4 Dec 2024 | 2025 Q1 Mar 2025 | 2025 Q2 Jun 2025 | 2025 Q3 Sept 2025 | 2025 Q4 Dec 2025 | 2026 Q1 Mar 2026 | 2026 Q2 Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Income | ||||||||
| Revenue | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Gross profit | −0 | −0 | 0 | 0 | −0 | 0 | 0 | 0 |
| EBITDA | −0 | −1 | −3 | −3 | −4 | −6 | −4 | −3 |
| Operating income | −1 | −1 | −3 | −3 | −4 | −6 | −4 | −3 |
| Net income | −1 | −2 | −11 | −12 | −8 | −6 | −6 | −4 |
| Diluted EPS | −$0.11 | −$0.27 | −$1.37 | −$1.14 | −$0.59 | −$0.08 | −$0.33 | −$0.18 |
| Growth (year on year) | ||||||||
| Revenue | −38.7% | −73.4% | +123.9% | +246.1% | +169.3% | +526.3% | −64.4% | −59.2% |
| Margins | ||||||||
| Gross margin | −30.0% | −355.5% | 36.3% | 46.0% | −99.7% | 20.5% | 34.6% | 3.2% |
| EBITDA margin | −465.0% | <−999% | −349.1% | −427.6% | <−999% | <−999% | <−999% | <−999% |
| Operating margin | −524.4% | <−999% | −356.8% | −438.8% | <−999% | <−999% | <−999% | <−999% |
| Net margin | −612.1% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% |
| Free-cash-flow margin | −515.0% | −887.1% | −76.4% | −196.7% | −525.6% | −562.8% | −600.2% | −635.4% |
| Cash flow | ||||||||
| Cash from operations | −1 | −1 | −1 | −1 | −1 | −2 | −2 | −2 |
| Capital spending | 0 | 0 | 0 | 0 | 0 | −0 | 0 | 0 |
| Free cash flow | −1 | −1 | −1 | −1 | −2 | −2 | −2 | −2 |
| Stock-based pay | −0 | 0 | 9 | 4 | −7 | 12 | 2 | 2 |
| Free cash flow after stock pay | −0 | −1 | −10 | −6 | 5 | −15 | −4 | −4 |
| Last 12 months unless stated | CITR | SNES | BYAH | REFR | ZONE | YMAT | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $1m | $2m | $3m | $654232 | $3m | $10m | $906m |
| Revenue growth, last 12 months | −26.4% | 13.4% | 6.0% | −46.5% | 64.2% | −43.5% | 5.4% |
| Revenue growth, 3-year average | 134.1% | 29.8% | — | −2.9% | — | — | 0.9% |
| Revenue growth, latest quarter | −59.2% | 23.2% | — | −33.5% | −0.8% | — | 8.3% |
| Gross margin | −5.2% | 66.2% | 94.4% | — | 37.8% | 54.1% | 28.8% |
| Operating margin | <−999% | −303.7% | −956.5% | −348.1% | <−999% | −207.7% | 4.3% |
| Operating margin, 3-year average | −992.9% | −353.6% | — | −210.0% | −711.2% | — | 5.5% |
| Net margin | <−999% | −294.7% | −965.0% | −343.9% | <−999% | −203.2% | 0.8% |
| Cash from operations / revenue | −576.8% | −281.4% | 3.4% | −238.6% | −533.5% | −31.8% | 6.9% |
| Free-cash-flow margin | −579.5% | −283.7% | −0.1% | −238.6% | −534.7% | −33.9% | 4.3% |
| Free-cash-flow margin, 3-year average | −301.2% | −342.6% | — | −148.0% | −248.7% | — | 5.1% |
| Stock pay / revenue | 742.9% | 12.1% | 953.3% | 33.2% | 271.1% | 0.9% | 1.0% |
| Change in share count | 93.5% | 74.4% | 17.8% | 1.5% | — | 3.8% | 0.1% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | -26.4% | 6.0% | 38 of 42 |
| Change in growth rate Growth | -57.0pp | +1.3pp | 40 of 42 |
| Gross margin Profitability | -5.2% | 31.5% | 38 of 40 |
| Operating margin Profitability | -1330.5% | 3.8% | 38 of 39 |
| Net margin Profitability | -1788.4% | 1.7% | 41 of 42 |
| Free-cash-flow margin Cash generation | -579.5% | 4.8% | 42 of 42 |
| Stock pay as % of revenue Cash generation | 742.9% | 1.0% | 35 of 36 |
| Long-term debt as % of assets Balance sheet | 0.0% | 26.8% | 1 of 36 |
| Days sales outstanding Balance sheet | 45 days | 59 days | 8 of 30 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Products Sale | $1.3M | 56.7% | ▲ 115.4% |
| Product Installation Service | $1M | 43.3% | ▲ 467.2% |
From Citrotech Inc.'s 10-K filed March 30, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Vanguard Capital Management LLC | $2.7M | 487K | 33.8% | ▲ 14.7% |
| Fifth Third Bancorp | $1.3M | 235K | 16.3% | ▲ 94.2% |
| Geode Capital Management, LLC | $973,325 | 176K | 12.2% | ▲ 15.5% |
| Cerity Partners LLC | $559,038 | 101K | 7.0% | New |
| Vanguard Fiduciary Trust Co | $522,330 | 95K | 6.6% | ▲ 40.8% |
| State Street Corp | $351,348 | 64K | 4.4% | ▲ 446.4% |
| T3 Companies, LLC | $226,226 | 41K | 2.8% | ▲ 63.9% |
| Wealth Enhancement Advisory Services, LLC | $211,065 | 41K | 2.7% | New |
| Northern Trust Corp | $209,589 | 38K | 2.6% | ▲ 44.7% |
| Blackrock, Inc. | $205,239 | 37K | 2.6% | New |
| Susquehanna International Group, LLP | $182,679 | 33K | 2.3% | ▼ 60.2% |
| Fny Investment Advisers, LLC | $152,000 | 28K | 1.9% | ▲ 200.1% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Citrotech Inc.'s complete shareholder register. Values are as reported by the filers ; 3 inconsistently scaled filing rows were excluded.
| Insider | Date | Trade | Shares | Price | Value |
|---|---|---|---|---|---|
| Huff Craig A Director | October 22, 2026 | Buy | 200,000 | $2.50 | $500,000 |
| Conboy Stephen 10% owner | August 4, 2026 | Sell | 275,001 | $3.00 | $825,003 |
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| Financial statements | SEC 10-K and 10-Q filings | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
